About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Texas | 1,777 Studies

Clinical Trials Breast CancerTexas

Breast Cancer Clinical Trials in Texas

Find 1,777 clinical trials for breast cancer near Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1721-1740 of 1,777 trials

CompletedFirst Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursThe purpose of this study is to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Antitumor Activity of AZD8701 Alone and in Combination…NCT04504669·Baltimore, Maryland and 12 others CompletedPhase I/II Study of PDR001 in Patients With Advanced MalignanciesThe purpose of this "first-in-human" study of PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of PDR001…NCT02404441·Baltimore, Maryland and 40 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxThis phase Ib trial tests the safety, side effects, and best dose of tumor treating fields therapy in combination with either cabozantinib or nab-paclitaxel and atezolizumab in…NCT05092373·Houston, Texas

CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

TerminatedDose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsPrimary Objectives: Part 1 (Dose Escalation) * To determine the MTD/maximum administered dose (MAD) of SAR443216 administered as a single agent in participants with HER2…NCT05013554·Houston, Texas and 10 others

UnknownThe Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast CancerThe purpose of this study is to evaluate the biodistribution and dosimetry of single dose of 99mTc-glycopeptide (99mTc-GP, 20-25 mCi) in 3 different doses of GP (5, 10and 20 mg)in…NCT01159405·Houston, Texas

CompletedSoy Isoflavones and Breast Cancer Risk ReductionSoy consumption has been associated with reduced risk for developing breast cancer. Soy contains isoflavones which are weak estrogens.NCT00204490·Galveston, Texas

TerminatedPROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsThe purpose of this first-in-human study of CX-2009 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-2009 in…NCT03149549·Los Angeles, California and 25 others

No longer availableExpanded Access to ANG1005 for Individual PatientsThis is an expanded access study with ANG1005 treatment for two individual patients from Protocol ANG1005-CLN-03 with WHO Grade III Anaplastic Astrocytoma and WHO Grade III…NCT02755987·Orange, California and 1 other

CompletedPanitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerThe goal of this clinical research study is to learn how effective the combination of chemotherapy including both panitumumab, Abraxane (nab-paclitaxel), and carboplatin (PNC) and…NCT01036087·Houston, Texas

RecruitingFulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast CancerThe study will investigate if CDK4/6 inhibitor holiday will reset the cell cycle process to respond to the combination of fulvestrant and abemaciclib, and this approach may…NCT05305924·Houston, Texas

UnknownA Study to Assess PV-10 Chemoablation of Cancer of the LiverThis open-label study will evaluate the safety, tolerability, pharmacokinetics and effect on tumor growth following a single intralesional injection of PV-10 in subjects with…NCT00986661·San Diego, California and 4 others

CompletedPROACT - Pre-Operative Arimidex Compared To TamoxifenThe purpose of this study is to compare tamoxifen, versus a newer treatment, ARIMIDEX, which we already know to be well tolerated.NCT00232661·Santa Rosa, California and 78 others

Active not recruitingTempus Priority Study: A Pan-tumor Observational StudyObservational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific…NCT05179824·Dallas, Texas and 1 other

CompletedA Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerThis study was a Phase III, randomized, double-blind, placebo-controlled, multicenter international clinical trial conducted to investigate the use of pertuzumab in combination…NCT00567190·Scottsdale, Arizona and 321 others

CompletedA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)This study is being conducted to determine if a combination of AZD6244 given orally twice a day with standard doses of selected chemotherapies will be safe and tolerable for…NCT00600496·Detroit, Michigan and 3 others

RecruitingIDOV-Immune for Advanced Solid TumorsThis is a Phase I clinical trial evaluating an investigational treatment called IDOV-Immune, a type of oncolytic virus therapy, for adults with advanced solid tumors that have not…NCT06910657·St Louis, Missouri and 4 others

CompletedA Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid TumorsIn this four-part study, NKTR-214 was administered in combination with nivolumab and with/without other anticancer therapies.NCT02983045·La Jolla, California and 57 others

UnknownCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsPhase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.NCT04660929·Duarte, California and 6 others

RecruitingJAB-2485 Activity in Adult Patients With Advanced Solid TumorsThis study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors.NCT05490472·Detroit, Michigan and 7 others

PreviousPage 87 of 89Next

Other Conditions in Texas

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma